U.S. Personal Products Stock News

In early February 2026, Science Applications International Corporation updated its outlook, cutting expected fiscal 2027 revenue to between US$7.0 billion and US$7.20 billion from US$7.35 billion to US$7.55 billion, and signaled an organic revenue decline tied to procurement delays and unfavorable recompete outcomes. Management also outlined a shift toward more selective, technology‑focused bids and mission and engineering work, indicating a meaningful recalibration of how the company...

Fortune Brands Innovations (NYSE:FBIN) appointed longtime board member and consumer products executive Amit Banati as CEO, effective May 2026. Banati will succeed Nicholas Fink, whose departure sets up a planned transition period for the company. Board chair Susan Kilsby will take on interim leadership responsibilities during the handover. The leadership change comes while the company is working through operational restructuring, margin pressures, and cost-saving efforts. For investors, the...

On February 11, 2026, TPG Inc. completed a long-term partnership with Jackson Financial Inc., including a US$500,000,000 common equity investment for roughly 6.5% of the company and a 10-year renewable investment management agreement. This deal meaningfully reshapes Jackson’s business mix by adding external asset-based finance and direct lending expertise to support its spread-focused annuity platform. Now we’ll examine how TPG’s US$500,000,000 equity infusion and investment management role...

Why Dole’s award winning pineapple matters for stock watchers Dole (DOLE) just picked up a 2026 Best New Product Award for its Colada Royale Pineapple, a variety developed over 15 years. The recognition is putting fresh attention on how product launches might influence the stock. See our latest analysis for Dole. The award comes as the share price sits at US$15.91 and recent momentum has been positive, with an 8.7% 30 day share price return and a 13.3% 90 day share price return. The 1 year...

If you are asking yourself whether McGraw Hill is priced attractively right now, this article will walk through what the current share price might be implying about the business. The stock last closed at US$13.67, with a recent 7 day return of 8.3%, a 30 day return of 5.7% decline, and a year to date return of 16.4% decline, which may have caught your eye if you are watching for changing risk and reward. Recent evergreen coverage interest around McGraw Hill has focused on how the market is...

Exact Sciences (EXAS) just reported its FY 2025 numbers with fourth quarter revenue of US$878.4 million, a basic EPS loss of US$0.45 and net income loss of US$86.0 million, while on a trailing twelve month basis revenue came in at about US$3.2 billion with a basic EPS loss of US$1.10 and a net income loss of US$207.9 million. The company has seen quarterly revenue move from US$713.4 million in Q4 2024 to US$878.4 million in Q4 2025, with basic EPS losses over that span ranging from US$4.67 to...

NCR Atleos award puts AI driven ATM capabilities in focus NCR Atleos (NATL) recently received the ATM Industry Association's Peter Kulik Innovation Award for its Intelligent Diagnostics platform, an AI based system that targets more accurate and efficient ATM service resolution. See our latest analysis for NCR Atleos. The award comes as NCR Atleos shares trade at $42.24, with recent AI driven product news and contract renewals, such as the Heart of England Co operative deal, coinciding with a...

NewMarket (NYSE:NEU) is seeing strong momentum in its Specialty Materials segment, helped by the acquisition of Calca Solutions and higher volumes at AMPAC. The company is contending with softer conditions and inflation pressures in its core Petroleum Additives business. NewMarket is putting capital into technology and capacity expansion while also returning substantial cash to shareholders. NewMarket, trading at about $592.8, has delivered a 67.3% return over 5 years and 82.1% over 3...

Illumina (NasdaqGS:ILMN) has partnered with the San Diego Zoo Wildlife Alliance to sequence and analyze thousands of endangered animal genomes. The collaboration centers on the world's largest biobank for endangered species, with the aim of supporting global wildlife conservation efforts. The project is expected to enable broad access to genomic data for conservation scientists and biodiversity managers. For investors watching Illumina, this move highlights how its sequencing platforms and...

Waste Connections (WCN) has drawn fresh attention after reporting fourth quarter and full year 2025 results that exceeded Wall Street expectations, along with margin expansion, active acquisitions, capital returns, and cautiously positive 2026 guidance. See our latest analysis for Waste Connections. Despite the upbeat earnings, buybacks and a confirmed quarterly dividend, the share price at US$160.26 reflects recent pressure. The 30 day share price return shows a decline of 4.1% and the 1...

In recent months, YETI Holdings reported solid quarterly results, but analysts highlighted that its long-term revenue growth has lagged sector expectations and that projections indicate weaker free cash flow margins and a lower return on invested capital ahead. This combination of resilient near-term performance with signs of pressure on future profitability has drawn attention to how effectively YETI can convert its strong brand into sustained, high-quality cash generation. We’ll now...

Why sentiment has turned cautious on Sana Biotechnology (SANA) Sana Biotechnology (SANA) has come under pressure after a recent analyst downgrade, just as the FDA increases regulatory scrutiny on gene therapies, putting extra focus on the company’s upcoming quarterly results and cash position. See our latest analysis for Sana Biotechnology. At a share price of US$3.85, Sana’s recent 30 day share price return of 15.94% and year to date share price return of 8.11% contrast with a 1 year total...

If you are wondering whether Berkshire Hathaway's current share price still makes sense for long term investors, you are not alone. That is exactly what this article will focus on. The stock most recently closed at US$751,424.99, with returns of 1.4% over 30 days, 1.0% year to date, 4.5% over 1 year, 60.8% over 3 years and 106.2% over 5 years. These figures raise fair questions about how its current price lines up with underlying value. Recent headlines have continued to highlight...

In early February 2026, Tyson Foods completed a US$498.17 million fixed-rate senior unsecured bond offering and confirmed its quarterly dividend, following first-quarter 2026 results that showed higher sales of US$14,313 million but lower net income of US$85 million versus a year earlier. These moves came as Tyson’s beef operations continued to struggle with very large beef price increases and historically tight US cattle supplies, putting sustained pressure on profitability. Now we’ll...

Sabra Health Care REIT (NasdaqGS:SBRA) has appointed Darrin Smith as Chief Investment Officer, Secretary, and Executive Vice President following the retirement of Talya Nevo-Hacohen. The company reports strong operational execution, with gains in occupancy, NOI, and margin within its senior housing portfolio. Sabra highlights an investment pipeline for 2026 that it expects to exceed already high 2025 levels. Sabra Health Care REIT, trading at around $20.17, enters this management transition...

If you are wondering whether Diversified Energy's current share price lines up with its underlying worth, you are not alone. This article aims to unpack exactly that. The stock most recently closed at US$13.21, with returns of a 1% decline over 7 days, 5.9% over 30 days, a 10.7% decline year to date and a 16.9% decline over 1 year. This extends to a 40.9% decline over 3 years and a 58.7% decline over 5 years. Recent coverage around Diversified Energy has focused on how investors interpret...

In recent weeks, Sonoco Products Company appointed First Citizens BancShares CFO Craig L. Nix, CPA, to its Board of Directors and committees overseeing audit and financial policy, affirmed a US$0.53 quarterly dividend marking 100 years and 403 consecutive quarters of payouts, and initiated a major virtual power purchase agreement with ENGIE’s Big Sampson Wind Project. Together, these moves highlight Sonoco’s emphasis on experienced financial oversight, long-running cash returns to...

Why Universal Health Services is on investors’ radar today Universal Health Services (UHS) has drawn fresh attention after a period of solid recent returns, with the stock up 0.3% over the past day and 7.4% over the past week. That short term move comes alongside gains of 17.5% over the past month and 3.7% over the past 3 months. These moves are prompting investors to look more closely at what they are paying for the company’s earnings and cash flows. See our latest analysis for Universal...

TriNet Group (NYSE:TNET) has introduced an AI-powered TriNet Assistant to support clients with HR tasks. The company is also expanding its TriNet Ascend sales training program into additional U.S. regions. These moves represent new product and talent development efforts beyond routine financial updates. TriNet Group comes into this news with a share price of $39.82 and a value score of 5, alongside multi year share price pressure. The stock has seen a 28.8% decline over the past week, 36.5%...

Morningstar, Inc. reported past fourth-quarter 2025 results with revenue rising to US$641.1 million from US$591.0 million a year earlier, while diluted earnings per share from continuing operations edged up to US$2.83 from US$2.71. For the full year 2025, management highlighted that revenue, operating income, and adjusted operating income all increased, as earnings per share from continuing operations improved to US$8.87 on a diluted basis. We’ll now examine how this earnings beat and solid...

New Zealand trial approval and what it could mean for Sarepta shares Sarepta Therapeutics (SRPT) is in focus after New Zealand regulator Medsafe cleared its clinical trial application for SRP-1005, enabling a first-in-human Phase 1 study in Huntington's Disease. See our latest analysis for Sarepta Therapeutics. The Medsafe decision lands after a tough stretch for Sarepta investors, with a 30 day share price return of 15.81% and a year to date share price return decline of 16.52%, while the 1...

Purion H6 launch shifts focus to Axcelis Technologies stock Axcelis Technologies (ACLS) has introduced its Purion H6 high current ion implanter, a new system aimed at next generation semiconductor manufacturing. This launch is putting fresh attention on how the product might influence the stock. See our latest analysis for Axcelis Technologies. The Purion H6 announcement comes after a period of solid share price momentum, with a 1 day share price return of 4.43%, a 7 day return of 9.84% and a...

Dover Corporation’s Board of Directors recently declared a regular quarterly cash dividend of US$0.52 per share, payable on March 13, 2026, to shareholders of record as of February 27, 2026. This dividend declaration follows strong Q4 2025 results with organic revenue growth, higher bookings, and adjusted earnings per share that exceeded prior guidance. Against this backdrop of stronger-than-expected earnings and higher 2026 guidance, we’ll assess how the update influences Dover’s investment...

CME Group has recently reported higher fourth-quarter and full-year 2025 earnings, raised its regular dividend to US$1.30 per share, and outlined multiple new futures launches spanning single stocks, rare earths, cryptocurrencies and South Asia edible oils. The combination of expanded product breadth across equities, commodities and digital assets and a larger cash return to shareholders underscores CME’s effort to broaden its fee base while deepening client engagement. We’ll now examine how...